Alkalihalobacillus clausii

iNtRON identifies Prophage and Jamphage in the Pancreatic cancer related Microbiome

Retrieved on: 
Tuesday, May 30, 2023

BOSTON and SEOUL, South Korea, May 29, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com ) has announced today the identification of Prophage and (non-) ORF-Jamphage from the microbiome frequently observed in long-term Pancreatic cancer survivors.

Key Points: 
  • BOSTON and SEOUL, South Korea, May 29, 2023 /PRNewswire/ -- iNtRON Biotechnology ("iNtRON", www.intodeworld.com ) has announced today the identification of Prophage and (non-) ORF-Jamphage from the microbiome frequently observed in long-term Pancreatic cancer survivors.
  • The ultimate goal is to develop phage-based immunotherapeutics capable of treating a range of immune disorders including cancer.
  • The primary focus of the company lies in Colorectal cancer and Pancreatic cancer.
  • Alkalihalobacillus clausii has been identified as a representative microbiome, and iNtRON has obtained the strain and confirmed the presence of Prophage and Jamphage through the genomic analysis.